Work

Real-world retinal vasculitis events reported with FDA-approved intravitreal anti-VEGF and complement inhibitor agents: an analysis of FAERS data

Year: 2026

Type: article

Study design: Observational Study

Source: Retina

DOI: 10.1097/iae.0000000000004980

Authors: Jay Chhablani, Ashraya Nayaka, Elham Sadeghi, Guruprasad B

Institution: University of Pittsburgh

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7203907431

FWCI:

Cites:

Cited by:

Related to: